CD8A and neoplasm: In tumor-associated macrophages (TAMs), YTHDF2 promotes a protumoral polarization state and suppresses antigen-presentation programs; myeloid-specific Ythdf2 loss reprograms TAMs toward antitumor phenotypes and enhances CD8+-mediated control in vivo.